Issues to Debate on the Women's Health Initiative Study: Failure of Estrogen Plus Progestin Therapy for Prevention of Breast Cancer Risk

Human Reproduction - United Kingdom
doi 10.1093/humrep/deg305
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Oxford University Press (OUP)

Related search

Conduct of the Women's Health Initiative Randomised Trial Evaluating Estrogen Plus Progestin: Implications for Breast Cancer Findings: Authors’ Response

Journal of Family Planning and Reproductive Health Care
2013English

Colorectal Cancer in Relation to Postmenopausal Estrogen and Estrogen Plus Progestin in the Women's Health Initiative Clinical Trial and Observational Study

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2009English

Breast Cancer After Use of Estrogen Plus Progestin in Postmenopausal Women

Yearbook of Anesthesiology and Pain Management
2010English

Breast Cancer After Use of Estrogen Plus Progestin in Postmenopausal Women

Yearbook of Oncology
2010English

Estrogen Plus Progestin and Breast Cancer Incidence and Mortality in Postmenopausal Women

Breast Diseases
OncologySurgery
2011English

Estrogen Plus Progestin Use, Microsatellite Instability, and the Risk of Colorectal Cancer in Women

Cancer Research
Cancer ResearchOncology
2007English

Pet Ownership and Cancer Risk in the Women's Health Initiative

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2016English

Update: Estrogen and Estrogen Plus Progestin Therapy in the Care of Women at and After the Menopause

Women's Health
Medicine
2012English

Progestin Therapy of Breast Cancer: Comparison of Agents.

BMJ
1967English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy